ID   HDC-101
AC   CVCL_A372
SY   HDC101
DR   ColonAtlas; HDC101
DR   Cosmic; 715198
DR   Cosmic; 2301981
DR   GEO; GSM1346837
DR   Wikidata; Q54882132
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
RX   PubMed=24755471;
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=1980607; DOI=10.1002/gcc.2870020112;
RA   Bruderlein S., van der Bosch K., Schlag P.M., Schwab M.;
RT   "Cytogenetics and DNA amplification in colorectal cancers.";
RL   Genes Chromosomes Cancer 2:63-70(1990).
//
RX   PubMed=7812507; DOI=10.1007/BF00196144;
RA   Koretz K., Bruderlein S., Henne C., Fietz T., Laque M., Moller P.;
RT   "Comparative evaluation of integrin alpha- and beta-chain expression
RT   in colorectal carcinoma cell lines and in their tumours of origin.";
RL   Virchows Arch. 425:229-236(1994).
//
RX   PubMed=8168998; DOI=10.1002/ijc.2910570314;
RA   Moller P., Koretz K., Leithauser F., Bruderlein S., Henne C.,
RA   Quentmeier A., Krammer P.H.;
RT   "Expression of APO-1 (CD95), a member of the NGF/TNF receptor
RT   superfamily, in normal and neoplastic colon epithelium.";
RL   Int. J. Cancer 57:371-377(1994).
//
RX   PubMed=24755471; DOI=10.1158/0008-5472.CAN-14-0013;
RA   Mouradov D., Sloggett C., Jorissen R.N., Love C.G., Li S.,
RA   Burgess A.W., Arango D., Strausberg R.L., Buchanan D., Wormald S.,
RA   O'Connor L., Wilding J.L., Bicknell D.C., Tomlinson I.P.M., Bodmer W.F.,
RA   Mariadason J.M., Sieber O.M.;
RT   "Colorectal cancer cell lines are representative models of the main
RT   molecular subtypes of primary cancer.";
RL   Cancer Res. 74:3238-3247(2014).
//